These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3114651)

  • 1. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clorgyline on the release of noradrenaline from rat vas deferens.
    Ari G; Finberg JP
    Eur J Pharmacol; 1992 Aug; 219(1):89-96. PubMed ID: 1397052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.
    Finberg JP; Tal A
    Br J Pharmacol; 1985 Mar; 84(3):609-17. PubMed ID: 2985158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of alpha-2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition.
    Finberg JP; Ari G; Lavian G; Hovevey-Sion D
    J Neural Transm Suppl; 1990; 32():405-12. PubMed ID: 1965197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V; Pycock CJ; Sandler M
    Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
    Finberg JP; Tenne M
    Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.
    Finberg JP; Tenne M; Youdim MB
    Br J Pharmacol; 1981 May; 73(1):65-74. PubMed ID: 6793119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.
    Finberg JP; Pacak K; Kopin IJ; Goldstein DS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):500-5. PubMed ID: 8391652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat anococcygeus muscle and vas deferens.
    Gillespie JS; McGrath JC
    Br J Pharmacol; 1974 Dec; 52(4):585-90. PubMed ID: 4455333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
    Hovevey-Sion D; Kopin IJ; Stull RW; Goldstein DS
    Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.
    Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):621-30. PubMed ID: 3444479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase: an important intracellular regulator of gastrin release in the rat.
    Dial EJ; Huang J; Delansorne R; Lichtenberger LM
    Gastroenterology; 1986 Apr; 90(4):1018-23. PubMed ID: 3081396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amiloride on contractions and the release of tritium from rat vas deferens preloaded with [3H]-noradrenaline.
    Akhtar-Khavari F; Khoyi MA; Rezaei E
    Br J Pharmacol; 1981 Sep; 74(1):123-7. PubMed ID: 7272596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of forskolin in rat vas deferens--evidence for facilitatory beta-adrenoceptors.
    Hovevei-Sion D; Finberg JP; Bomzon A; Youdim MB
    Eur J Pharmacol; 1983 Nov; 95(3-4):295-9. PubMed ID: 6140180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
    Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.